Or. Admin. Code § 845-025-7120

Current through Register Vol. 63, No. 10, October 1, 2024
Section 845-025-7120 - Cannabinoid Products Other than Cannabinoid Edibles, Topicals, Tinctures or Capsules.

Prior to a cannabinoid product other than a cannabinoid edible, topical, tincture or capsule being sold or transferred to a consumer, patient or designated primary caregiver, the container holding the product must have a label that has the following information:

(1) Processor's business or trade name, license number, and place of address;
(2) Business or trade name of licensee, license number, and place of address for licensee that packaged the product, if different from the processor;
(3) Product identity;
(4) UID number;
(5) Date the product was made;
(6) Net weight or volume in U.S. customary and metric units;
(7) Serving size and number of servings per container;
(8) Amount, in milligrams, of THC and CBD in each serving and in the container;
(9) List of all ingredients in descending order of predominance by weight or volume used to process the cannabinoid product;
(10) Name of the lab that performed any test and any test analysis date;
(11) Universal symbol;
(12) Activation time expressed in words or through a pictogram;
(13) A statement that reads: "This product is not approved by the FDA to treat, cure, or prevent any disease";
(14) For cannabinoid products for sale to a consumer, warnings that state:
(a) "For use only by adults 21 and older. Keep out of reach of children."
(b) "Do not drive a motor vehicle while under the influence of marijuana."
(c) "DO NOT EAT" in bold, capital letters.
(15) For medical grade cannabinoid products for use by a patient, the medical grade symbol and medical warnings that state:
(a) "For use by OMMP patients only. Keep out of reach of children."
(b) "Do not drive a motor vehicle while under the influence of marijuana."
(c) "DO NOT EAT" in bold, capital letters.
(16) For inhalable cannabinoid products that contain non-cannabis additives:
(a) The product identity must clearly identify that the product contains non-cannabis additives and, in addition to the other requirements of OAR 845-025-7000 through 845-025-7190, must include the words "non-cannabis additive."
(b) In addition to the other ingredients in the inhalable cannabinoid product, for each non-cannabis additive used, the ingredient listing must contain the words "non-cannabis additive" in a manner that clearly distinguishes each additive from any other additives.
(c) All of the ingredients in the non-cannabis additive:
(A) Must match the ingredients identified on the list of ingredients required by OAR 845-025-3265(1);
(B) Must be listed either alphabetically or in descending order of predominance by weight or volume; and
(C) Must be listed on:
(i) The label's ingredient list as sub-ingredients of the ingredient term "non-cannabis additive"; or
(ii) An insert within the product's container that clearly indicates that the ingredients listed are contained within the inhalable cannabinoid product.

Or. Admin. Code § 845-025-7120

OLCC 6-2018, adopt filed 05/23/2018, effective 6/1/2018; OLCC 24-2020, amend filed 12/21/2020, effective 12/22/2020; OLCC 154-2022, minor correction filed 03/25/2022, effective 3/25/2022

Statutory/Other Authority: ORS 475C.604, 475C.233 & 475C.237

Statutes/Other Implemented: ORS 475C.604